Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Haady Fallah & Marius Rademaker. (2022) Isotretinoin for acne vulgaris – an update on adverse effects and laboratory monitoring. Journal of Dermatological Treatment 33:5, pages 2414-2424.
Read now
Read now
Adam P. Bray, Georgios Kravvas, Suzanne M. Skevington & Christopher R. Lovell. (2019) Is there an association between isotretinoin therapy and adverse mood changes? A prospective study in a cohort of acne patients. Journal of Dermatological Treatment 30:8, pages 796-801.
Read now
Read now
Articles from other publishers (21)
Ana Beatriz Campos de Souza & Milena Nunes Alves de Sousa. (2022) EFEITOS PSICOLÓGICOS ASSOCIADOS AO USO DA ISOTRETINOÍNA. Revista Contemporânea 2:3, pages 1038-1052.
Crossref
Crossref
Jan Kapała, Julia Lewandowska, Waldemar Placek & Agnieszka Owczarczyk-Saczonek. (2022) Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis. International Journal of Environmental Research and Public Health 19:11, pages 6463.
Crossref
Crossref
J. Douglas Bremner. (2021) Isotretinoin and neuropsychiatric side effects: Continued vigilance is needed. Journal of Affective Disorders Reports 6, pages 100230.
Crossref
Crossref
Nkemjika Ugonabo, Elyse Love, Priscilla W. Wong, Evan A. Rieder, Seth J. Orlow, Randie H. Kim & Arielle R. Nagler. (2021) Psychiatric disorders and suicidal behavior in patients with acne prescribed oral antibiotics versus isotretinoin: Analysis of a large commercial insurance claims database. Journal of the American Academy of Dermatology 85:4, pages 878-884.
Crossref
Crossref
Matthew DeLuca, Maxsaya Baez Nuñez, Ezequiel Rodriguez & Krishan Chirimunj. (2021) Isotretinoin in Acne Vulgaris Complicated by Underlying Major Depression: A Case Report and Review of Literature. Case Reports in Psychiatry 2021, pages 1-4.
Crossref
Crossref
Megan N. Landis. (2020) Optimizing Isotretinoin Treatment of Acne: Update on Current Recommendations for Monitoring, Dosing, Safety, Adverse Effects, Compliance, and Outcomes. American Journal of Clinical Dermatology 21:3, pages 411-419.
Crossref
Crossref
Justin W. Marson & Hilary E. Baldwin. (2019) An Overview of Acne Therapy, Part 2. Dermatologic Clinics 37:2, pages 195-203.
Crossref
Crossref
Changqiang Li, Jianmei Chen, Wo Wang, Ming Ai, Qi Zhang & Li Kuang. (2019) Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis. BMJ Open 9:1, pages e021549.
Crossref
Crossref
A.U. Tan, B.J. Schlosser & A.S. Paller. (2018) A review of diagnosis and treatment of acne in adult female patients. International Journal of Women's Dermatology 4:2, pages 56-71.
Crossref
Crossref
João Miguel Oliveira, Gonçalo Sobreira, Jorge Velosa, Diogo Telles Correia & Paulo Filipe. (2017) Association of Isotretinoin With Depression and Suicide: A Review of Current Literature. Journal of Cutaneous Medicine and Surgery 22:1, pages 58-64.
Crossref
Crossref
Yu-Chen Huang & Ying-Chih Cheng. (2017) Isotretinoin treatment for acne and risk of depression: A systematic review and meta-analysis. Journal of the American Academy of Dermatology 76:6, pages 1068-1076.e9.
Crossref
Crossref
Melinda Liu, Yuan Yu M. Huang, Sylvia Hsu & Joseph S. Kass. (2016) Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications. CNS Drugs 30:12, pages 1149-1168.
Crossref
Crossref
Andrea L. Zaenglein, Arun L. Pathy, Bethanee J. Schlosser, Ali Alikhan, Hilary E. Baldwin, Diane S. Berson, Whitney P. Bowe, Emmy M. Graber, Julie C. Harper, Sewon Kang, Jonette E. Keri, James J. Leyden, Rachel V. Reynolds, Nanette B. Silverberg, Linda F. Stein Gold, Megha M. Tollefson, Jonathan S. Weiss, Nancy C. Dolan, Andrew A. Sagan, Mackenzie Stern, Kevin M. Boyer & Reva Bhushan. (2016) Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology 74:5, pages 945-973.e33.
Crossref
Crossref
Bella Suarez, Ana Serrano, Yves Cova & Trino Baptista. (2016) Isotretinoin was not associated with depression or anxiety: A twelve-week study. World Journal of Psychiatry 6:1, pages 136.
Crossref
Crossref
Noel Prevost & Joseph C. EnglishIIIIII. (2013) Isotretinoin: Update on Controversial Issues. Journal of Pediatric and Adolescent Gynecology 26:5, pages 290-293.
Crossref
Crossref
. (2013) Isotretinoin therapy for acne is associated with controversial issues regarding specific adverse effects. Drugs & Therapy Perspectives 29:10, pages 321-323.
Crossref
Crossref
Howard B. Pride, Megha Tollefson & Robert Silverman. (2013) What's new in pediatric dermatology?. Journal of the American Academy of Dermatology 68:6, pages 899.e1-899.e11.
Crossref
Crossref
Angelo Massimiliano D’Erme, Sara Pinelli, Alberto Cossidente, Eleonora Campolmi, Torello Lotti & Massimo Gola. (2013) Association between isotretinoin and mood changes: Myth or reality? An updated overview. International Journal of Dermatology 52:4, pages 499-500.
Crossref
Crossref
Stephen E. Wolverton & Julie C. Harper. (2013) Important Controversies Associated with Isotretinoin Therapy for Acne. American Journal of Clinical Dermatology 14:2, pages 71-76.
Crossref
Crossref
Matthew V. Rudorfer & Mi Hillefors. (2012) Assessing Psychiatric Adverse Effects during Clinical Drug Development. Pharmaceutical Medicine 26:6, pages 363-394.
Crossref
Crossref
Yara Dadalti Fragoso, Kirsty D. Shearer, Angelo Sementilli, Leda Viegas de Carvalho & Peter J. McCaffery. (2011) High expression of retinoic acid receptors and synthetic enzymes in the human hippocampus. Brain Structure and Function 217:2, pages 473-483.
Crossref
Crossref